Clinical Trial Update: Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04) [NA]

View source ↗

Summary

The SHIP trial (LMI-001-A-S04), sponsored by the National Cancer Institute, is evaluating self-collection for HPV testing to improve cervical cancer prevention …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Human Papillomavirus Infection

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Cervical Carcinoma, Human Papillomavirus Infection | NA | Status: RECRUITING